What is Flibanserin and what is it used for?

Flibanserin is a treatment related to sexual health. Hi-Doctor does not prescribe it today, but our licensed doctors can review your case and propose sexual health alternatives with robust clinical evidence and EU regulatory approval.

Why does Hi-Doctor not prescribe Flibanserin?

Our doctors only prescribe treatments with robust clinical evidence, an EU-approved indication and a reviewed safety profile. Flibanserin is not on that list today — it may be investigational, not approved, or outside the scope of what we handle via telemedicine.

What alternatives can I consider within sexual health?

Our doctors review your history and propose the most appropriate treatment among those authorised in the EU for sexual health. The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; sexual health remains a €35 one-off consultation. If your case is not eligible, the applicable fee is refunded.

How would my sexual health consultation work?

You fill in an online medical questionnaire (~4 min). An EU-licensed doctor reviews it and replies in less than 4 hours on average via the private chat in your account. If eligible, they issue a prescription electronic prescription valid in any EU pharmacy.

Can I get a consultation for Flibanserin from Wroclaw?

Yes. Hi-Doctor runs 100 % online across the EU, so if you live in Wroclaw you can fill in the questionnaire and receive the medical review without travelling. The electronic prescription issued by the licensed doctor is valid in any EU pharmacy under Directive 2011/24/EU; outside Spain, the pharmacist dispenses the locally marketed equivalent of the same active ingredient.

Is my sexual health consultation fully confidential?

Yes. All communication happens in the private chat of your account, GDPR-compliant. The doctor treats discretion as a core of the service and there is no history visible outside your consultation.

What is the private electronic prescription and why is it valid across the EU?

The private electronic prescription (Receta Médica Privada Electrónica) is issued by a licensed doctor in Spain. It is a PDF carrying every field required by EU Directive 2011/24/EU (patient, prescriber with country of registration, active ingredient, dose), which makes it legally recognised across all 27 EU member states. In Spanish pharmacies it is dispensed from the QR; outside Spain, the pharmacist dispenses the locally marketed equivalent of the same active ingredient.

How does Hi-Doctor work step by step?

1) Fill in an online medical questionnaire in about 4 minutes. 2) The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; sexual health is €35 per consultation and a skin consultation is €40. 3) An EU-licensed doctor reviews your case and, if appropriate, issues an electronic prescription. 4) Collect it at any EU pharmacy. If the review is not approved, the applicable fee is refunded in full.

How much does it cost and what does the price include?

The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; a one-off sexual-health consultation is €35 and a skin consultation — acne, rosacea, melasma, ageing skin — is €40. Each includes a licensed doctor's review and an electronic prescription if approved. If the review is not approved, the applicable fee is refunded in full. Medication is paid for separately at the pharmacy at the price it sets.

Flibanserin pack shot — a prescription medicine an EU-licensed doctor can prescribe online after a Hi-Doctor consultation in Wroclaw.

Flibanserin · Wroclaw

Flibanserin in Wroclaw: what you should know.

NOT AVAILABLE IN THE EUFlibanserin has no EU marketing authorisation for this use.

We don't prescribe it today, but our doctors can review your case and propose an equivalent sexual health treatment with EU approval and clinical evidence.

Review my sexual health case

€35 one-offFull refund if a review is not approved

IN PLAIN TERMS

What Flibanserin is, and how to get treatment

Flibanserin, sold in the United States as Addyi, is a tablet taken every night at bedtime for premenopausal women whose low sexual desire causes them real distress. It is not a hormone and it is not the female version of an erection tablet: it slowly adjusts brain chemical signalling and can take weeks before any effect shows. It has never been authorised anywhere in the European Union, so no EU doctor can prescribe it and Hi-Doctor does not offer it. Its best-known safety problem is alcohol: drinking close to a dose can cause a sharp drop in blood pressure and fainting, which is why the US label carries a boxed warning and rules about waiting at least two hours after a drink.

Flibanserin has no EU marketing authorisation for this use. It may be an approved medicine for something else, or approved in another country — but not something a doctor here can prescribe for this.

Can I get it?

Not for this use. Flibanserin has no EU authorisation for it, so it cannot be prescribed or dispensed here for that purpose.

Why buying it online is risky

What can I take instead?

Our doctors review every Sexual health option and recommend what fits your history and goals.

See all Sexual health options

What do the studies show?

Every trial behind Flibanserin is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.

Jump to the studies

Local consultation facts

Can I get Flibanserin in Wrocław?

Not through Hi-Doctor. Hi-Doctor does not prescribe Flibanserin. People in Wrocław, Poland, can request an online consultation for Sexual health with a licensed EU doctor, who may recommend an available option when clinically appropriate. If approved, the EU prescription arrives as a PDF for a pharmacist in Poland, who dispenses the locally marketed equivalent with the prescribed active ingredient.

Availability

Hi-Doctor does not prescribe Flibanserin. The links below show options in Sexual health that our doctors can assess.

Country: Poland
Language of service: Spanish and English
Prescription turnaround: In less than 4 hours on average, only if the doctor approves
Honoured locally: PDF honoured locally for the prescribed active ingredient

How the EU prescription works where you are: In Poland, show the approved prescription PDF to a pharmacist. They honour it under EU cross-border rules and dispense the locally marketed equivalent with the prescribed active ingredient.

Topical option for patients who don't respond to PDE5 inhibitors or have contraindications. The doctor assesses suitability.

Topical cream

€35 one-off

You pay for any medication separately at the pharmacy you choose. Hi-Doctor does not sell medications.

WHAT IT COSTS

One plan, reviewed by a doctor.

Sexual health

ONE-OFF

€35 one-off

One consultation, one doctor, one decision.

Nothing stored publicly, ever

Start consultation

Full refund if a review is not approved

WHAT'S INCLUDED

Consultation reviewed by an EU-licensed doctor
Electronic prescription if approved
Full refund if not approved

Full refund if a review is not approved

If a review is not approved, we refund the €35 consultation fee in full.

Read the refund terms

Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.

VERIFIED EVIDENCE

Flibanserin: evidence and regulatory guide.

WHAT IT IS

How it works

Flibanserin is a nightly tablet that gradually shifts the balance of serotonin, dopamine and noradrenaline signalling in the brain; it is not a hormone and does not change blood flow.

5-HT1A
5-HT2A

DEVELOPMENT STAGE

Not marketed in the EU

Trial register2 registered trials

Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.

Registered trials for Flibanserin
TRIAL / NCT	POPULATION	PARTICIPANTS	STATUS	READOUT / COMPLETION
BEGONIANCT00996164	Premenopausal women with hypoactive sexual desire disorder, mean age 36.6 years, at US sites	1,090	Read out	—
Phase 3 trial of flibanserin 50 mg and 100 mg each evening in women with hypoactive sexual desire disorder (North America)NCT00360529	Women with hypoactive sexual desire disorder at US and Canadian sites	880	Read out	—

What the studies reported

Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.

Peer-reviewed

Katz M, DeRogatis LR, Ackerman R, et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med 2013;10(7):1807-1815. doi:10.1111/jsm.12189 (PMID 23672269)

Katz M, DeRogatis LR, Ackerman R, et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med 2013;10(7):1807-1815. doi:10.1111/jsm.12189 (PMID 23672269)
DOSE OR GROUP	MEAN WEIGHT CHANGE	WEEKS
100 mg at bedtime (n=542) vs placebo (n=545)	Satisfying sexual events per 28 days increased by 2.5 on flibanserin and 1.5 on placebo (P ≤ 0.0001)	24
100 mg at bedtime (n=542) vs placebo (n=545)	Female Sexual Function Index desire domain increased by 1.0 on flibanserin and 0.7 on placebo (P ≤ 0.0001)	24
100 mg at bedtime (n=542) vs placebo (n=545)	Distress about low desire (FSDS-R item 13) changed by −1.0 on flibanserin and −0.7 on placebo	24

The trial ran for 24 weeks in North America and the difference from placebo amounted to roughly one extra satisfying sexual event per month; the placebo group also improved substantially.

Sources

Last reviewed 2026-07-27

NAMED SAFETY SIGNALS

What has been reported with Flibanserin.

Alcohol interaction (boxed warning)

The US label carries a boxed warning that taking flibanserin and alcohol close together in time increases the risk of severe low blood pressure and fainting. At first approval in 2015 alcohol was an outright contraindication; the warning was revised in 2019 to tell patients to wait at least two hours after one or two standard drinks before taking the tablet.

Severe low blood pressure and fainting from drug and liver interactions

The US label contraindicates flibanserin with moderate or strong CYP3A4 inhibitors and in anyone with liver impairment, because severe hypotension and syncope can occur.

Dizziness

Reported by 11.4% of premenopausal women on flibanserin versus 2.2% on placebo.

Sleepiness

Somnolence reported by 11.2% of premenopausal women on flibanserin versus 2.9% on placebo.

Nausea

Reported by 10.4% of premenopausal women on flibanserin versus 3.9% on placebo.

Fainting recorded in trials

Syncope was recorded in 0.4% of premenopausal women on flibanserin versus 0.2% on placebo, and hypotension in 0.2% versus less than 0.1%.

Stopping treatment because of side effects

In the BEGONIA trial 9.6% of women on flibanserin discontinued because of adverse events, versus 3.7% on placebo.

UNAPPROVED PRODUCTS ONLINE

Why buying Flibanserin online is not a shortcut.

No doctor in the EU can prescribe it for this use — including ours. It may be authorised in another country, or for a different condition.

Check the EU common logo

A legitimate online pharmacy in the EU must display the common logo linked to its national register. The logo is a verification check; it cannot make an unapproved medicine legal.

How the EU common logo works

FREQUENTLY ASKED QUESTIONS